VR-111

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameVR-111
Drug Alias Nametherapeutic recombinant HPV 16 E7-HBcAg-Hsp65 fusion protein vaccine (Shanghai Zerun Biotechnology)therapeutic recombinant human papillomavirus 16 E7-HBcAg-Hsp65 fusion protein vaccine (Shanghai Zerun Biotechnology)VR-111
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion proteinVaccines > Development/production technology > Inactivated vaccine > Subunit vaccineVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsPapillomavirus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaDiscontinued
Originator CompaniesShanghai Zerun Biotechnology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesShanghai Zerun Biotechnology Co Ltd
Active IndicationsN/A
Inactive IndicationsPapillomavirus Infections

Other Information

ATC CodeN/A
Related LinksN/A